Chemical inhibitors of MSAP can interfere with various signaling pathways and cellular processes to inhibit the protein's function. Cyclosporin A, for example, suppresses the activity of calcineurin, which is vital for dephosphorylating nuclear factor of activated T-cells (NFAT), a transcription factor that can regulate genes involved in MSAP-related pathways. This suppression can downregulate the signaling pathways that MSAP is involved in, leading to its functional inhibition. Rapamycin targets the mTOR pathway, a central regulator of cell growth and proliferation, and by inhibiting mTOR, the synthesis of proteins including MSAP can be indirectly reduced, leading to the diminished functional capacity of MSAP.
Similarly, WZB117 inhibits GLUT1, thereby limiting the glucose uptake necessary for the energy-dependent functions of MSAP, while Brefeldin A disrupts the Golgi apparatus, halting the processing and trafficking of proteins such as MSAP. Triacsin C targets acyl-CoA synthetase, crucial for lipid biosynthesis, potentially impeding the proper localization and function of MSAP within cellular membranes. Inhibition of MEK by PD98059 can lead to decreased ERK pathway signaling, which is implicated in various cellular processes, including those in which MSAP may play a role. LY294002's action upon PI3K can disrupt AKT signaling, disturbing downstream processes essential for MSAP activity. GW4869, by inhibiting sphingomyelinase, can alter membrane composition and thus signaling pathways where MSAP operates. ML7 inhibits myosin light chain kinase, which is important for cytoskeletal dynamics and membrane interactions, processes that are important for the functional integrity of MSAP. U73122's inhibitory effect on phospholipase C can disrupt signaling cascades significant for MSAP's role, and the inhibition of protein kinase C by Go6983 can impair pathways necessary for MSAP function. Lastly, SB203580 targets p38 MAP kinase, which can disturb cellular stress responses and other pathways involving MSAP, leading to its functional inhibition. Each of these chemicals acts upon a specific aspect of cellular function that is critical for the activity of MSAP, thereby inhibiting its role within the cell.
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
Cyclosporin A inhibits calcineurin, which subsequently reduces NFAT activity that can downregulate MSAP-involved signaling pathways. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
Rapamycin inhibits mTOR, which is part of the pathway involved in the regulation of protein synthesis, including those like MSAP. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $48.00 $122.00 $432.00 $812.00 | 4 | |
WZB117 inhibits glucose transporter 1 (GLUT1), potentially reducing energy supply necessary for MSAP's functional processes. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $30.00 $52.00 $122.00 $367.00 | 25 | |
Brefeldin A disrupts Golgi apparatus function, which can inhibit the processing and trafficking of proteins such as MSAP. | ||||||
Triacsin C Solution in DMSO | 76896-80-5 | sc-200574 sc-200574A | 100 µg 1 mg | $149.00 $826.00 | 14 | |
Triacsin C inhibits acyl-CoA synthetase, potentially reducing lipid synthesis required for proper membrane localization of MSAP. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
PD98059 inhibits MEK, which may in turn inhibit ERK pathway signaling involved in processes necessary for MSAP function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002 inhibits PI3K, potentially disrupting AKT signaling and downstream processes that could be vital for MSAP activity. | ||||||
GW4869 | 6823-69-4 | sc-218578 sc-218578A | 5 mg 25 mg | $199.00 $599.00 | 24 | |
GW4869 inhibits sphingomyelinase, possibly disrupting membrane composition and signaling pathways wherein MSAP is active. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
ML7 inhibits myosin light chain kinase, which can disrupt cytoskeletal dynamics and membrane interactions important for MSAP. | ||||||
Gö 6983 | 133053-19-7 | sc-203432 sc-203432A sc-203432B | 1 mg 5 mg 10 mg | $103.00 $293.00 $465.00 | 15 | |
Go6983 inhibits protein kinase C, which can impair signaling pathways that are necessary for the proper function of MSAP. | ||||||